Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Dongni Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-7487-5813; OpenAlex author ID A5083988880. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Quantitative definitions of pain, CA19-9, and tumor size as high-risk features of resectable pancreatic cancer: a single-center retrospective cohort study. Co-author DOI 10.21037/gs-20-877↗
  2. HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. First author DOI 10.1016/j.ebiom.2019.05.013↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanan Lu · 1 shared paper, 2021 · strength 0.15
  2. Yanan Lu · 1 shared paper, 2019 · strength 0.09
  3. Zhaofan Luo · 1 shared paper, 2019 · strength 0.09
  4. Zhi Wang · 1 shared paper, 2019 · strength 0.09
  5. Huimou Chen · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.